Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
Clinical trial NCT05758896 · COMPLETED
Trial details
- NCT number
- NCT05758896
- Sponsor
- Aptabio Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-27
- Primary completion
- 2026-07-22
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.